Clinical Trial Update: A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study in Japan evaluating PF-00299804 in patients with advanced malignant solid tumors has completed, focusing on safety and tolerability with prelimina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• PF-00299804

Snippet

Sponsor: Pfizer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED